Extracellular vesicle separation method, colloidal particle and preparation method thereof
AssigneeIndustrial Technology Research Institute
InventorsYu-Fang Yen, Chien-An Chen, Cheng-Tai Chen
Life of this patent
Estimating the term…
Abstract
An extracellular vesicle separation method, a colloidal particle, and a preparation method thereof are provided. The colloidal particle is used for extracellular vesicle separation, and includes 2 wt % to 6 wt % of agarose. The colloidal particle has a particle size of 25 μm to 500 μm, and is surface-modified with biocompatible molecules. The biocompatible molecules include sodium carboxymethyl cellulose (CMC), methyl cellulose (MC), glycine, aspartic acid, glutamic acid, bovine serum albumin (BSA), fetal bovine serum (FBS), or a combination thereof.
Claims15
A preparation method of a colloidal particle, the colloidal particle being used for extracellular vesicle separation, and the preparation method comprising:
- preparing an agarose solution with a concentration of 2 wt % to 6 wt % with water and agarose and heating the agarose solution to 90° C. to 100° C., and adding a surfactant with a concentration of 5 wt % to 20 wt % and a mineral oil with a concentration of 50 wt % to 60 wt % into the agarose solution for emulsification to form a first colloidal material;
- sieving the first colloidal material with a sieve to obtain a second colloidal material with a particle size ranging from 25 μm to 500 μm, and washing the second colloidal material with a detergent to remove oil stains and impurities;
- adding a cross-linking agent with a concentration of 0.1 M to 0.5 M into the washed second colloidal material to form a third colloidal material through stirring;
- and
- washing the third colloidal material with an organic solvent, and then surface-modifying the third colloidal material with a modification solution to obtain a colloidal particle surface-modified with biocompatible molecules,
- wherein the modification solution comprises sodium carboxymethyl cellulose (CMC), methyl cellulose (MC), glycine, aspartic acid, glutamic acid, bovine serum albumin (BSA), fetal bovine serum (FBS), or a combination thereof.
A colloidal particle used for extracellular vesicle separation, wherein the colloidal particle comprises 2 wt % to 6 wt % of agarose, the colloidal particle has a particle size of 25 μm to 500 μm, and the colloidal particle is surface-modified with biocompatible molecules, wherein the biocompatible molecules comprises sodium carboxymethyl cellulose (CMC), methyl cellulose (MC), glycine, aspartic acid, glutamic acid, bovine serum albumin (BSA), fetal bovine serum (FBS), or a combination thereof.
Dependencies are inferred from the claim text.